We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478490 (+12)

1.14% more ownership

Funds ownership: 78.38%79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M
Name Holding Trade Value Shares
Change
Change in
Stake
NMERB
276
New Mexico Educational Retirement Board
New Mexico
$816K
UIM
277
USS Investment Management
United Kingdom
$812K
RIM
278
Redwood Investment Management
Arizona
$805K +$786K +1,381 New
SC
279
Sepio Capital
Utah
$793K -$258K -453 -25%
DT
280
Diversified Trust
Tennessee
$790K +$121K +212 +19%
SC
281
SRB Corp
Massachusetts
$777K +$121K +212 +19%
SIM
282
Sentry Investment Management
Wisconsin
$776K
KRS
283
Kentucky Retirement Systems
Kentucky
$760K +$30.8K +54 +4%
DC
284
Derby & Company
Massachusetts
$758K
LSERS
285
Louisiana State Employees Retirement System
Louisiana
$758K +$114K +200 +18%
E
286
Ergoteles
New York
$758K +$740K +1,300 New
Commonwealth Equity Services
287
Commonwealth Equity Services
Massachusetts
$754K -$312K -548 -30%
IMRF
288
Illinois Municipal Retirement Fund
Illinois
$753K +$356K +625 +94%
Daiwa Securities Group
289
Daiwa Securities Group
Japan
$746K +$4.56K +8 +0.6%
SP
290
Symmetry Partners
Connecticut
$729K +$570 +1 +0.1%
CA
291
Capitolis Advisors
New York
$728K +$711K +1,248 New
Nordea Investment Management
292
Nordea Investment Management
Sweden
$711K +$2.85K +5 +0.4%
AA
293
AQR Arbitrage
Connecticut
$706K +$703K +1,235 New
AB
294
Amalgamated Bank
New York
$701K -$1.14K -2 -0.2%
AIA
295
Angeles Investment Advisors
California
$690K -$106K -186 -14%
NMIMC
296
Northwestern Mutual Investment Management Company
Wisconsin
$688K +$3.42K +6 +0.5%
CWM
297
Chesapeake Wealth Management
Virginia
$680K +$29.6K +52 +5%
O
298
Ossiam
France
$669K -$239K -420 -27%
WCM
299
Weld Capital Management
New York
$655K +$640K +1,124 New
VIA
300
Vident Investment Advisory
Georgia
$645K +$6.83K +12 +1%

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.